{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:09:02Z","timestamp":1743134942246,"version":"3.40.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00406-023-01718-3","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T06:51:21Z","timestamp":1710831081000},"page":"565-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients"],"prefix":"10.1007","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9662-7242","authenticated-orcid":false,"given":"Nina Kim","family":"Bekier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Frischknecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Eidenmueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Stenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derik","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"6","key":"1718_CR1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/clpt.2011.188","volume":"90","author":"DI Abrams","year":"2010","unstructured":"Abrams DI, Couey P, Shade SB, Kelly M, Benowitz NL (2010) Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther 90(6):844\u2013841","journal-title":"Clin Pharmacol Ther"},{"key":"1718_CR2","unstructured":"Aharonovich E, Garawi F, Bisaga A, Brooks D, Raby WN, Rubin E, Australian Institute of Health and Welfare (2002) 2001 national drug strategy household survey: first results. Curr Psychiatry Rep 61"},{"issue":"10","key":"1718_CR3","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","volume":"174","author":"MA Bachhuber","year":"2014","unstructured":"Bachhuber MA, Saloner B, Cunningham CO, Barry CL (2014) Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999\u20132010. JAMA Intern Med 174(10):1668\u20131673","journal-title":"JAMA Intern Med"},{"key":"1718_CR4","unstructured":"Bet\u00e4ubungsmittel-Verschreibungsverordnung vom 20. Januar 1998 (BGBl. I S. 74, 80), die zuletzt durch Artikel 2 der Verordnung vom 18. Mai 2021 (BGBl. I S. 1096) ge\u00e4ndert worden ist, \u00a75"},{"issue":"1","key":"1718_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coph.2009.09.009","volume":"10","author":"I Bushlin","year":"2010","unstructured":"Bushlin I, Rozenfeld R, Devi LA (2010) Cannabnoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol 10(1):80\u201386","journal-title":"Curr Opin Pharmacol"},{"issue":"10","key":"1718_CR6","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1177\/0269881112443745","volume":"26","author":"JJ Byrnes","year":"2012","unstructured":"Byrnes JJ, Johnson NL, Schenk ME, Byrnes EM (2012) Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring. J Psychopharmacol 26(10):1348\u20131354. https:\/\/doi.org\/10.1177\/0269881112443745. (Epub 2012 Apr 19)","journal-title":"J Psychopharmacol"},{"key":"1718_CR7","volume-title":"National drug strategy","author":"F Darke","year":"2007","unstructured":"Darke F (2007) National drug strategy. Dept. of Health and Aged Care, Canberra"},{"issue":"11","key":"1718_CR8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1360-0443.2007.01980.x","volume":"102","author":"S Darke","year":"2007","unstructured":"Darke S, Duflou J, Kaye S (2007) Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims. Addiction 102(11):1793\u20131797 (Epub 2007 Sep 3)","journal-title":"Addiction"},{"key":"1718_CR9","unstructured":"Drogen- und Suchtbericht Oktober 2020 https:\/\/bit.ly\/2vv2ZtB"},{"issue":"8","key":"1718_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41386-021-01007-4","volume":"46","author":"KE Dunn","year":"2021","unstructured":"Dunn KE, Bergeria CL, Huhn AS, Speed TJ, Mun CJ, Vandrey R, Campbell CM (2021) Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharmacology 46(8):1451\u20131459. https:\/\/doi.org\/10.1038\/s41386-021-01007-4. (Epub 2021 Apr 20)","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1718_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1360-0443.2005.01322.x","volume":"101","author":"DM Fergusson","year":"2006","unstructured":"Fergusson DM, Boden JM, Horwood LJ (2006) Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101(4):556\u2013569","journal-title":"Addiction"},{"key":"1718_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.addbeh.2017.10.013","volume":"77","author":"F Heidebrecht","year":"2018","unstructured":"Heidebrecht F, MacLeod MB, Dawkins L (2018) Predictors of heroin abstinence in opiate substitution therapy in heroin-omly users and dualusers of heroin and crack. Addict Behav 77:210\u2013216","journal-title":"Addict Behav"},{"issue":"1","key":"1718_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mi.5.1.6","volume":"5","author":"SR Hursh","year":"2005","unstructured":"Hursh SR, Galuska CM, Winger G, Woods JH (2005) The economics of drug abuse: a quantitative assassment of drug demand. Mol Interv 5(1):20\u201328","journal-title":"Mol Interv"},{"issue":"1","key":"1718_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12954-021-00520-5","volume":"18","author":"SL Kvamme","year":"2021","unstructured":"Kvamme SL, Pedersen MM, R\u00f8mer Thomsen K, Thylstrup B (2021) Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduct J 18(1):72. https:\/\/doi.org\/10.1186\/s12954-021-00520-5","journal-title":"Harm Reduct J"},{"issue":"8","key":"1718_CR15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/FBP.0b013e32835a3907","volume":"23","author":"JX Li","year":"2012","unstructured":"Li JX, Koek W, France CP (2012) Interactions between \u0394 (9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys. Behav Pharmacol 23(8):754\u2013761","journal-title":"Behav Pharmacol"},{"issue":"3","key":"1718_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","volume":"298","author":"AH Lichtman","year":"2001","unstructured":"Lichtman AH, Sheikh SM, Loh HH, Martin BR (2001) Opioid and cannabinoid modulation of precipitated withdrawal in delta (9)-tetrahydrocannabinol and morphine-dependent mice. J Pharmacol Exp Ther 298(3):1007\u20131014","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1718_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/16066359.2012.733465","volume":"21","author":"P Lucas","year":"2013","unstructured":"Lucas P, Reiman A, Earleywine M, McGowan SK, Oleson M, Coward MP, Thomas B (2013) Cannabis as a substitute for alcohol and other drugs: a dispensery-based survey of substitution effect in Canadian medical cannabis patients. Addiction Res Theory 21(5):435\u2013442","journal-title":"Addiction Res Theory"},{"issue":"3","key":"1718_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/dar.12323","volume":"35","author":"P Lucas","year":"2016","unstructured":"Lucas P, Walsh Z, Crosby K, Callaway R, Belle-Isle L, Kay R, Capler R, Holtzman S (2016) Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: the impact of contextual factors. Drug and Alcohol Rev 35(3):326\u2013333","journal-title":"Drug and Alcohol Rev"},{"key":"1718_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.633168","volume":"12","author":"CA MacCallum","year":"2021","unstructured":"MacCallum CA, Eadie L, Barr AM, Boivin M, Lu S (2021) Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Front Pharmacol 12:633168. https:\/\/doi.org\/10.3389\/fphar.2021.633168","journal-title":"Front Pharmacol"},{"key":"1718_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejphar.2017.11.038","volume":"819","author":"DR Maguire","year":"2018","unstructured":"Maguire DR, France CP (2018) Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio. Eur J Pharmacol 819:217\u2013224. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.038. (Epub 2017 Nov 26)","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1718_CR21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.113.204099","volume":"345","author":"DR Maguire","year":"2013","unstructured":"Maguire DR, Yang W, France CP (2013) Interactions between \u00b5-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination and drug self-administration. J Pharmacol Exp Ther 345(3):354\u2013362","journal-title":"J Pharmacol Exp Ther"},{"issue":"2\u20133 Spec Issue","key":"1718_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/FBP.0000000000000192","volume":"27","author":"DR Maguire","year":"2016","unstructured":"Maguire DR, Yang W, France CP (2016) Interactions of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys. Behav Pharmacol 27(2\u20133 Spec Issue):249\u2013257","journal-title":"Behav Pharmacol"},{"issue":"7","key":"1718_CR23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.7326\/M23-0053","volume":"176","author":"EE McGinty","year":"2023","unstructured":"McGinty EE, Tormohlen KN, Seewald NJ, Bicket MC, McCourt AD, Rutkow L, White SA, Stuart EA (2023) Effects of U.S. State medical cannabis laws on treatment of chronic noncancer pain. Ann Internal Med 176(7):904\u2013912. https:\/\/doi.org\/10.7326\/M23-0053","journal-title":"Ann Internal Med"},{"issue":"14","key":"1718_CR24","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2018.0158","volume":"319","author":"AH Mokdad","year":"2018","unstructured":"Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi R, Ferrari AJ, Kasaeian A, Werdecker A, Carter A, Zipkin B, Sartorius B, Serdar B, Sykes BL, Troeger C, Fitzmaurice C, Rehm CD, Santomauro D, Kim D, Colombara D, Schwebel DC, Tsoi D, Kolte D, Nsoesie E, Nichols E, Oren E, Charlson FJ, Patton CG, Roth GA, Hosgood HD, Whitford HA, Kyu H, Erskine HE, Huang H, Martopullo I, Singh JA, Nachega JB, Sanabria JR, Abbas K, Ong K, Tabb K, Krohn KJ, Cornaby L, Degenhardt L, Moses M, Farvid M, Griswold M, Criqui M, Bell M, Nguyen M, Wallin M, Mirarefin M, Qorbani M, Younis M, Fullman N, Liu P, Briant P, Fona P, Havmollet R, Leung R, Kimokoti R, Bazargan-Hejazi S, Hay SI, Yadgir S, Birjyukov S, Vollset SE, Alam T, Frank T, Farid T, Miller T, Vos T, B\u00e4rnihausen T, Gebrehlwot TT, Yano Y, Al-Aly Z, Mehari A, Handal A, Kandel A, Anderson B, Biroscak B, Mozaffarian D, Dorsey ER, Ding EL, Park EK, Wagner G, Hu G, Chen H, Sunshine JE, Khubchandani J, Leasher J, Leung J, Salomon JE, Unutzer J, Cahil L, Cooper L, Horino M, Brauer M, Breitborde N, Hotez P, Topor-Madry R, Soneji S, Stranges S, James S, Amrock S, Jayaraman S, Patel T, Akinyemiju T, Skirbekk V, Kinfu Y, Bhutta JB, Murray CJL (2018) The state of US health, 1999\u20132016: burden of diseases, injuries and risk factors among Us states. JAMA 319(14):1444\u20131472. https:\/\/doi.org\/10.1001\/jama.2018.0158. (Published online 2018 Apr 10)","journal-title":"JAMA"},{"issue":"11","key":"1718_CR25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/npp.2009.70","volume":"34","author":"LJ Morel","year":"2009","unstructured":"Morel LJ, Giros B, Daug\u00e9 V (2009) Adolescent exposure to chronic delt-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology 34(11):2469\u20132476","journal-title":"Neuropsychopharmacology"},{"key":"1718_CR26","unstructured":"National Institute on Drug Abuse (2018) Opioid overdoses by state. National Institutes of Health. https:\/\/www.drugabuse.gov\/drug-topics\/opioids\/opioid-summaries-by-state\/california-opioid-involved-deaths-related-harms"},{"issue":"14","key":"1718_CR27","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M Navarro","year":"2001","unstructured":"Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, de Fonseca FR (2001) functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci. 21(14):5344\u20135350","journal-title":"J Neurosci."},{"issue":"15","key":"1718_CR28","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1097\/00001756-199810260-00012","volume":"9","author":"M Navarro","year":"1998","unstructured":"Navarro M, Chowen J, Carrera MRA, del Arco I, Villan\u00faa MA, Martin Y, Roberts AJ, Koob GF, de Fonseca FR (1998) CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats. NeuroReport 9(15):3397\u20133402","journal-title":"NeuroReport"},{"issue":"6","key":"1718_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7517-6-35","volume":"2009","author":"A Reiman","year":"2009","unstructured":"Reiman A (2009) Cannabis as a substitute for alcohol and other drugs. Harm Reduct J 2009(6):35","journal-title":"Harm Reduct J"},{"issue":"17","key":"1718_CR30","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1097\/00001756-200112040-00017","volume":"12","author":"C Salio","year":"2001","unstructured":"Salio C, Fischer J, Franzoni MF, Mackie K, Taneko T, Conrath M (2001) CB-1 Cannabinid and \u00b5-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. NeuroReport 12(17):3689\u20133692","journal-title":"NeuroReport"},{"issue":"17","key":"1718_CR31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroscience.2013.04.034","volume":"248","author":"JL Scavone","year":"2013","unstructured":"Scavone JL, Sterling RC, Van Bockstale EJ (2013) Cannabinoid and opiod interactions: implications for opiate dependence and withdrawal. Neuroscience 248(17):637\u2013654","journal-title":"Neuroscience"},{"issue":"7","key":"1718_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.7216","volume":"2","author":"LE Segura","year":"2019","unstructured":"Segura LE, Mauro CM, Levy NS, Khauli N, Philbin MM, Mauro OM, Martins SS (2019) Association of US medical marijuana laws with nonmedical prescription opioid use and prescription opioid use disorder. JAMA Netw Open 2(7):e197216. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.7216","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1718_CR33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.forsciint.2006.09.003","volume":"170","author":"G Skopp","year":"2007","unstructured":"Skopp G, Strohbeck-Kuehner P, Mann K, Hermann D (2007) Deposition of cannabinoids in hair after long-term use of cannabis. Forensic Sci Int 170(1):46\u201350","journal-title":"Forensic Sci Int"},{"key":"1718_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnmol.2020.00054","volume":"13","author":"RA Slivicki","year":"2020","unstructured":"Slivicki RA, Iyer V, Mali SS, Garai S, Thakur GA, Crystal JD, Hohmann AG (2020) Positive allosteric modulation of CB1-cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine- induced dependence or reward. Front Mol Neurosci. 13:54. https:\/\/doi.org\/10.3389\/fnmol.2020.00054","journal-title":"Front Mol Neurosci."},{"issue":"12","key":"1718_CR35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11848","volume":"12","author":"KM Takakuwa","year":"2020","unstructured":"Takakuwa KM, Sulak D (2020) A survey on the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites. Cureus 12(12):e11848. https:\/\/doi.org\/10.7759\/cureus.11848","journal-title":"Cureus"},{"issue":"2","key":"1718_CR36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","volume":"81","author":"D Vigan\u00f2","year":"2005","unstructured":"Vigan\u00f2 D, Rubino T, Parolaro D (2005) Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Bichem Behav 81(2):360\u2013368","journal-title":"Pharmacol Bichem Behav"},{"key":"1718_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","volume":"51","author":"Z Walsh","year":"2017","unstructured":"Walsh Z, Gonzalez R, Crosby K, Thiessen MS, Carroll C, Bonn-Miller MO (2017) Medical cannabis and mental health: a guided systematic review. Clin Psychol Rev 51:15\u201329. https:\/\/doi.org\/10.1016\/j.cpr.2016.10.002","journal-title":"Clin Psychol Rev"},{"issue":"5","key":"1718_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamainternmed.2018.1007","volume":"178","author":"H Wen","year":"2028","unstructured":"Wen H, Hockenberry JM (2028) Association of medical and adult-use marijuana laws with opioid prescribing for medicaid enrollees. JAMA Intern Med 178(5):673\u2013679. https:\/\/doi.org\/10.1001\/jamainternmed.2018.1007","journal-title":"JAMA Intern Med"},{"issue":"1\u20132","key":"1718_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(01)02655-5","volume":"909","author":"T Yamaguchi","year":"2001","unstructured":"Yamaguchi T, Hagiwara T, Tanaka H, Sugiura S, Waku K, Shoyama Y, Watanabe S, Yamamoto T (2001) Endogenous cannabinoid, 2-arachidonoylglygerol, attenuaes naloxone-precipitated withdrawal signs in morphine-dependent mice. Brain Res 909(1\u20132):121\u2013126","journal-title":"Brain Res"},{"key":"1718_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.632757","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang H, Lipinski AA, Liktor-Busa E, Smith AF, Moutal A, Khanna R, Langlais PR, Largent-Milnes TM, Vanderah TW (2021) The effects of repeated morphine treatment on the endogenous cannabinoid system in the ventral tegmental area. Front Pharmacol 12:632757. https:\/\/doi.org\/10.3389\/fphar.2021.632757","journal-title":"Front Pharmacol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-023-01718-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-023-01718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T20:11:17Z","timestamp":1743106277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-023-01718-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s00406-023-01718-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"type":"print","value":"0940-1334"},{"type":"electronic","value":"1433-8491"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nina Kim Bekier, Ulrich Frischknecht, Katharina Eidenmueller, Franz Grimm, Manuel Stenger, Patrick Bach, and Falk Kiefer declare that she\/ he has no conflict of interest. Author Derik Hermann has received speaker\/interview honorarium from the Drug Companies Indivior and Camurus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}